News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,259 Results
Type
Article (8016)
Company Profile (139)
Press Release (475008)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166739)
Career Advice (304)
Deals (25738)
Drug Delivery (8)
Drug Development (52874)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238192)
Policy (17898)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (483)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33162)
ALS (102)
Alzheimer's disease (966)
Antibody-drug conjugate (ADC) (255)
Approvals (10344)
Artificial intelligence (310)
ASCO (159)
Autoimmune disease (197)
Automation (28)
Bankruptcy (262)
Best Places to Work (6963)
BIO (36)
BIOSECURE Act (1)
Biosimilars (104)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (501)
Cancer (3568)
Cardiovascular disease (213)
Career advice (246)
Career pathing (1)
CAR-T (169)
Celiac Disease (1)
Cell therapy (469)
Cervical cancer (34)
Clinical research (47750)
Collaboration (1208)
Commercialization (1)
Compensation (1393)
Complete response letters (33)
COVID-19 (752)
CRISPR (62)
C-suite (709)
Cystic fibrosis (84)
Data (5516)
Denatured (4)
Depression (101)
Dermatology (60)
Diabetes (336)
Diagnostics (4154)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (146)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (158)
Earnings (73055)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87457)
Executive appointments (683)
FDA (12295)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (895)
Gene editing (123)
Generative AI (9)
Gene therapy (309)
GLP-1 (286)
Government (949)
Grass and pollen (2)
Guidances (280)
Healthcare (9319)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (97)
Immuno-oncology (55)
Indications (151)
Infectious disease (938)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (42)
IPO (12379)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (2)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Liver cancer (43)
Longevity (15)
Lung cancer (492)
Lymphoma (242)
Machine learning (27)
Management (3)
Manufacturing (513)
Marketing (7)
MASH (116)
Medical device (8636)
Medtech (8759)
Mergers & acquisitions (14354)
Metabolic disorders (692)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (213)
Neuropsychiatric disorders (38)
Neuroscience (1787)
NextGen: Class of 2026 (3153)
Non-profit (845)
Obesity (219)
Opinion (10)
Ovarian cancer (156)
Pain (169)
Pancreatic cancer (191)
Parkinson's disease (196)
Partnered (12)
Patents (458)
Patient recruitment (479)
Peanut (31)
People (41140)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15434)
Phase 2 (21322)
Phase 3 (14357)
Pipeline (6679)
Policy (18)
Postmarket research (1572)
Preclinical (6526)
Press Release (34)
Prostate cancer (187)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (557)
Real estate (3021)
Recruiting (6)
Regulatory (14703)
Reports (16)
Research institute (579)
Resumes & cover letters (46)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (99)
Series A (149)
Series B (118)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (49)
Vaccines (311)
Venture capital (17)
Weight loss (72)
Women's health (75)
Date
Today (39)
Last 7 days (253)
Last 30 days (1081)
Last 365 days (19070)
2026 (10799)
2025 (19253)
2024 (22985)
2023 (26538)
2022 (34587)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17469)
2017 (18765)
2016 (17917)
2015 (24264)
2014 (21683)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (71)
Alaska (2)
Arizona (293)
Arkansas (11)
Asia (17845)
Australia (2090)
California (11536)
Canada (3043)
China (505)
Colorado (465)
Connecticut (390)
Delaware (203)
Europe (24566)
Florida (1718)
Georgia (364)
Hawaii (2)
Idaho (46)
Illinois (680)
India (42)
Indiana (308)
Iowa (13)
Japan (387)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1155)
Massachusetts (7593)
Michigan (299)
Minnesota (540)
Mississippi (4)
Missouri (78)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2540)
New Mexico (12)
New York (2737)
North Carolina (1230)
North Dakota (4)
Northern California (5746)
Ohio (269)
Oklahoma (14)
Oregon (14)
Pennsylvania (2192)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4783)
Tennessee (114)
Texas (1860)
United States (37532)
Utah (345)
Vermont (1)
Virginia (146)
Washington D.C. (38)
Washington State (895)
West Virginia (1)
Wisconsin (73)
483,259 Results for "accellix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Accellix, Inc. and Streck Collaborate to Advance Cell Therapy with Quality Control
September 25, 2025
·
2 min read
Press Releases
Accellix Appoints Dr. Félix A. Montero-Julian as Vice President of Scientific Affairs
July 8, 2025
·
2 min read
Press Releases
Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets
September 24, 2024
·
2 min read
BioCapital
Accellix Raises $10 Million From BroadOak Capital Partners
Accellix Inc. announced that it has raised $10 million from BroadOak Capital Partners.
December 13, 2021
·
2 min read
Business
Accellix Expands its Leadership Team
Accellix Inc. is pleased to announce that Terrance Gin is joining its leadership team as Vice President Global Operations effective immediately.
May 11, 2021
·
2 min read
Biotech Bay
Accellix, Inc. Announces Their Next Generation Accellix Instrument and Consumable to Further Simplify and Automate the QC Workflow in Cell Therapy Manufacturing
Accellix, Inc. is launching its Next Generation Integrated Accellix Instrument and Consumables to further automate, simplify and improve reproducibility during the intricate process of QC for cell therapy manufacturing. Accellix entered the cell therapy market in 2017, automating the complete flow cytometry workflow, from sample preparation to analysis, which is considered the golden standard in QC.
April 29, 2020
·
2 min read
Biotech Bay
Accellix, Inc Expands Leadership Team and Announces Name Change
LeukoDx, Inc. (“the Company”), is pleased to announce the official name change to Accellix, Inc. (“Accellix”) effective immediately.
July 25, 2019
·
3 min read
Business
Orgenesis announces co-development agreement with Accellix
Agreement Integrates Accellix’s Proprietary Quality Control Optic System, Cartridges, Reagents and Software into Orgenesis’ Point of Care Cellular Therapy Platform
October 16, 2019
·
3 min read
Business
Accellix Announces the Appointment of Charles Piazza to its Board of Directors
Accellix Inc. announces the appointment of a new Board Member, Mr. Charles Piazza.
August 14, 2019
·
2 min read
Biotech Bay
Accellix, the Cell Therapy QC Company Raises $9.5 Million Series D Round
Today Accellix, the Cell Therapy QC company, announced a Series D financing round of $9.5 million led by bioMérieux, a world leader in the field of in vitro diagnostics for over 55 years. All existing major investors participated in this raise and have also agreed to convert their pre-existing convertible note in the amount of $8.5 million, bringing the company’s total funding in this round to $18 millio
June 11, 2020
·
2 min read
1 of 48,326
Next
